MedTrace Logo

Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

NCT05155072 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2021-12-13

No results posted yet for this study

Summary

A Randomized, Open-label, Oral in healthy male volunteers

Conditions

  • Gastritis

Interventions

DRUG

DW1903

DW1903

DRUG

DW1903-R1

DW1903-R1

DRUG

DW1903-R2

DW1903-R2

Sponsors & Collaborators

  • Daewon Pharmaceutical Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-15
Primary Completion
2020-09-07
Completion
2020-09-07

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05155072 on ClinicalTrials.gov